<i>Acinetobacter baumannii</i> Resistance to Sulbactam/Durlobactam: A Systematic Review
Infections caused by carbapenem-resistant <i>Acinetobacter baumannii</i> (CRAB) have limited therapeutic options. Sulbactam-durlobactam is a combination of two βlactamase inhibitors with activity against CRAB under phase 3 clinical investigation. We performed a systematic review on in vi...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-12-01
|
Series: | Antibiotics |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-6382/11/12/1793 |